Dr. | Manager Enabling Technologies
Tel. +41 61 295 50 20ralf. duempelmann@baselarea. swiss
Antibiotics often don’t work anymore due to increasing resistance of bacteria. Simple infections pose a deadly health threat to all of us.
It was and still is relatively unattractive to invest into new antibiotics development due to the low pricing situation and regulatory hurdles.
Today, the awareness for the need to research antibiotics is building up, governmental efforts are increasing and there are interesting funding opportunities for research in this field.
Currently a lot of action has been taken in finding new chemical spaces. Novel methods for example use microfluidics, phage therapies, resistance breaking strategies and concepts to boost the immune system.
As a hub for antibiotic research Basel is a fantastic place providing a critical mass in the life sciences community spanning from academic research to big and small pharma players.